Employers Weigh Costs and Benefits of GLP-1 Medication Coverage
As the use of GLP-1 medications for weight loss rises among U.S. adults, employers are facing a growing dilemma regarding coverage costs versus workforce benefits. While some major corporations like Walmart and Bank of America are committing significant resources to provide these drugs, approximately 10% of surveyed employers plan to scale back or drop weight management coverage in 2027 due to high expenses. For employees, access to GLP-1s is becoming a critical factor in job retention and recruitment, with surveys indicating that many workers would change jobs specifically for this coverage. Beyond physical health, research suggests these medications may mitigate workplace weight bias, potentially improving employment outcomes for certain demographics, though the long-term economic impact on corporate healthcare budgets remains a point of contention.
Topics: Employer-sponsored insurance GLP-1 medications Weight loss drugs Workplace benefits